Apple ramps 2nm orders amid persistent supply constraints

What happened

Apple has joined other major customers in increasing orders for TSMC's 2-nanometer family by 10% to 20%, pushing expected monthly capacity to about 120,000 wafers by the end of 2026. This move signals Apple's commitment to securing advanced-node supply for upcoming devices, even as the company braces for intensifying component shortages and rising costs across advanced semiconductors, NAND, and DRAM. The DeepValue report highlights Apple's own disclosures of supply constraints, with product gross margin supported by tariff refunds but pressured by memory inflation. While the order increase suggests confidence in future product demand, it also implies higher near-term capital commitments and potential cost headwinds. The stock has shown limited reaction to AI-related supply news, reflecting market focus on execution and margin sustainability.

Implication

Investors should view the 2nm order increase as a positive signal for Apple's next-generation product competitiveness, but it does not alleviate the current supply constraints and rising component costs that management expects to intensify into the next product cycle. Higher advanced-node orders may add to near-term capital expenditures and inventory obligations, which could pressure free cash flow and product gross margin if pricing power fails to offset input inflation. The news does not address the key catalysts of supply normalization, China Apple Intelligence launch, or margin sustainability without tariff refunds, which are necessary for a more constructive stance. At a P/E of 36.5 and EV/EBITDA of 32.9, the stock already prices in AI distribution strength, leaving limited upside until operational headwinds ease. Maintain a WAIT rating with attractive entry near $285 and trim above $350, focusing on upcoming quarterly filings for evidence of improved supply language and stable product margins.

Thesis delta

The increase in 2nm orders reinforces Apple's commitment to advanced silicon and long-term product differentiation, but it does not alter the near-term thesis. Supply constraints and cost inflation remain central risks, with product gross margin dependent on tariff refunds amid memory price increases. The WAIT rating remains appropriate, as the news is consistent with the existing concern that Apple is prioritizing advanced nodes while broader component shortages may limit unit production and margin expansion.